This federal contract award is for the delivery of Nexplanon 68 mg implants to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $3,573.45, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at up to $499,999,999. This IDC allows the DLA to place orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. As a prime vendor for the DLA, DMS Pharmaceutical Group provides both routine and specialized medications, including contraceptives, oncology drugs, and other pharmaceuticals, to serve the diverse medical requirements of the Department of Defense and its personnel.
Generated 12/26/24, 9:14 AM